These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 30808433
1. Localisation of basic fibroblast growth factor in cholesteatoma matrix: an immunochemical study. Hamed MA, Sayed RH, Shiogama K, Eltaher MA, Suzuki K, Nakata S. J Laryngol Otol; 2019 Mar; 133(3):183-186. PubMed ID: 30808433 [Abstract] [Full Text] [Related]
2. The role of S100A1 in external auditory canal cholesteatoma. Naim R, Hormann K. Oncol Rep; 2006 Oct; 16(4):671-5. PubMed ID: 16969478 [Abstract] [Full Text] [Related]
3. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Sudhoff H, Dazert S, Gonzales AM, Borkowski G, Park SY, Baird A, Hildmann H, Ryan AF. Am J Otol; 2000 Nov; 21(6):793-8. PubMed ID: 11078065 [Abstract] [Full Text] [Related]
4. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma. Sasaki H, Huang CC. Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866 [Abstract] [Full Text] [Related]
5. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma. Xie S, Wang X, Ren H, Liu X, Ren J, Liu W. Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080 [Abstract] [Full Text] [Related]
6. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis. Van Blitterswijk CA, Grote JJ, Lutgert RW, Hesseling SC, Out CJ, Van Muijen GN, Fransen JA. Ann Otol Rhinol Laryngol; 1989 Aug; 98(8 Pt 1):635-40. PubMed ID: 2475048 [Abstract] [Full Text] [Related]
12. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues. Broekaert D, Coucke P, Leperque S, Ramaekers F, Van Muijen G, Boedts D, Leigh I, Lane B. Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020 [Abstract] [Full Text] [Related]
14. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma. Kuczkowski J, Bakowska A, Pawelczyk T, Narozny W, Mikaszewski B. ORL J Otorhinolaryngol Relat Spec; 2006 Nov; 68(5):296-301. PubMed ID: 16825801 [Abstract] [Full Text] [Related]
15. Localization of interleukin-1 in human cholesteatoma. Ahn JM, Huang CC, Abramson M. Am J Otolaryngol; 1990 Nov; 11(2):71-7. PubMed ID: 2188520 [Abstract] [Full Text] [Related]
16. Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein. Huang CC, Chen CT, Huang TS, Shinoda H. Eur Arch Otorhinolaryngol; 1996 Nov; 253(7):385-9. PubMed ID: 8891480 [Abstract] [Full Text] [Related]
17. Expression of epidermal growth factor receptor in human middle ear cholesteatoma. Hsu YC, Ho KY, Chai CY, Lee KW, Wang LF, Wu SC, Kuo WR, Tsai SM. Kaohsiung J Med Sci; 2003 Oct; 19(10):497-502. PubMed ID: 14620675 [Abstract] [Full Text] [Related]
18. Lymphotoxin in human middle ear cholesteatoma. Yan SD, Huang CC. Laryngoscope; 1991 Apr; 101(4 Pt 1):411-5. PubMed ID: 1680210 [Abstract] [Full Text] [Related]
19. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Bujía J, Holly A, Schilling V, Negri B, Pitzke P, Schulz P. Laryngoscope; 1993 Mar; 103(3):326-9. PubMed ID: 7680089 [Abstract] [Full Text] [Related]
20. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study. Ergün S, Zheng X, Carlsöö B. Acta Otolaryngol; 1994 May; 114(3):295-302. PubMed ID: 7521107 [Abstract] [Full Text] [Related] Page: [Next] [New Search]